OneMedNet (NASDAQ: ONMD - Get Free Report) and Rapid7 (NASDAQ: RPD - Get Free Report) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk. Risk and Volatility OneMedNet has a beta

BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, today announced the winners of its 2026 Partner of the Year Awards. The annual awards program recognizes and honors partners around the globe for excellence in helping customers evolve their security programs to reduce risk earlier, operate more efficiently, and build lasting cyber resilience.

Rapid7, Inc. (RPD) Q4 2025 Earnings Call Transcript

The headline numbers for Rapid7 (RPD) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Rapid7 (RPD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.48 per share a year ago.

Annualized recurring revenue (“ARR”) of $840 million Full-year revenue of $860 million, increased 2% year-over-year Full-year net cash provided by operating activities of $154 million; free cash flow of $130 million BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (Nasdaq: RPD), a global leader in AI-powered managed cybersecurity operations, today announced its financial results for the fourth quarter and full year 2025. "Rapid7 exited 2025 delivering outperformance against fourth quarter ARR, revenue, and profitability guidance," said Corey Thomas, CEO of Rapid7.

Rapid7 (RPD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

/PRNewswire/ -- USA News Group News Commentary - Western capital markets are undergoing a structural realignment as defense technology investment reached $49.1

Rapid7 (NASDAQ: RPD - Get Free Report) and UiPath (NYSE: PATH - Get Free Report) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation and risk. Profitability This table compares Rapid7 and UiPath's net

Rapid7 (RPD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.